These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23749985)

  • 1. Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection.
    Numata M; Nagashima Y; Moore ML; Berry KZ; Chan M; Kandasamy P; Peebles RS; Murphy RC; Voelker DR
    J Lipid Res; 2013 Aug; 54(8):2133-2143. PubMed ID: 23749985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection.
    Numata M; Chu HW; Dakhama A; Voelker DR
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):320-5. PubMed ID: 20080799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung.
    Numata M; Grinkova YV; Mitchell JR; Chu HW; Sligar SG; Voelker DR
    Int J Nanomedicine; 2013; 8():1417-27. PubMed ID: 23717040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylglycerol suppresses influenza A virus infection.
    Numata M; Kandasamy P; Nagashima Y; Posey J; Hartshorn K; Woodland D; Voelker DR
    Am J Respir Cell Mol Biol; 2012 Apr; 46(4):479-87. PubMed ID: 22052877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol inhibits respiratory syncytial virus infection.
    Numata M; Kandasamy P; Nagashima Y; Fickes R; Murphy RC; Voelker DR
    J Lipid Res; 2015 Mar; 56(3):578-587. PubMed ID: 25561461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal administration of maleic anhydride-modified human serum albumin for pre-exposure prophylaxis of respiratory syncytial virus infection.
    Sun Z; Wang Q; Jia R; Xia S; Li Y; Liu Q; Xu W; Xu J; Du L; Lu L; Jiang S
    Viruses; 2015 Feb; 7(2):798-819. PubMed ID: 25690799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
    Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
    Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology.
    Yang J; Ma C; Zhao Y; Fan A; Zou X; Pan Z
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8
    Lee JY; Chang J
    J Microbiol; 2017 Nov; 55(11):900-908. PubMed ID: 29076066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus.
    Jiao YY; Fu YH; Yan YF; Hua Y; Ma Y; Zhang XJ; Song JD; Peng XL; Huang J; Hong T; He JS
    Antiviral Res; 2017 Aug; 144():57-69. PubMed ID: 28529001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice.
    Muralidharan A; Russell MS; Larocque L; Gravel C; Sauvé S; Chen Z; Li C; Chen W; Cyr T; Rosu-Myles M; Wang L; Li X
    Vaccine; 2019 Jul; 37(30):4031-4039. PubMed ID: 31186190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
    Shafique M; Wilschut J; de Haan A
    Vaccine; 2012 Jan; 30(3):597-606. PubMed ID: 22120195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu YH; He JS; Qiao W; Jiao YY; Hua Y; Zhang Y; Peng XL; Hong T
    Virol J; 2013 Jun; 10():183. PubMed ID: 23742026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
    Li L; Yu CH; Ying HZ; Yu JM
    J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
    Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease.
    Kotomina T; Isakova-Sivak I; Matyushenko V; Kim KH; Lee Y; Jung YJ; Kang SM; Rudenko L
    Antiviral Res; 2019 Aug; 168():9-17. PubMed ID: 31075351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
    Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-viral activity of jatrophone against RSV-induced respiratory infection via increase in interferon-γ generating dendritic cells.
    Li K; Xu Y; Yue W
    Environ Toxicol; 2020 Aug; 35(8):888-894. PubMed ID: 32267089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal vaccine against respiratory syncytial virus A and B subtypes.
    Lee JY; Chang J
    PLoS One; 2017; 12(4):e0175384. PubMed ID: 28384263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.